Boston Scientific hires cardiologist Ian Meredith as chief medical officer

Tim Casey | | Cardiovascular Business | Patient Care

Boston Scientific hired Ian Meredith, PhD, as executive vice president and global chief medical officer.

Meredith, a cardiologist, will begin his duties in January 2017 and succeed Keith Dawkins, MD, who has been the company’s chief medical officer since January 2012. Boston Scientific announced the moves in an Oct. 10 news release.

Meredith is a professor at Australia's Monash University, director of MonashHeart and Monash Health and executive director of the Monash cardiovascular research center in Melbourne, Australia. He has performed more than 10,000 invasive cardiac and coronary procedures, according to a news release.

Meredith has also been chief or principal investigator on 30 international, multicenter trials, including the Boston Scientific Lotus Valve Reprise research program.

In August, Boston Scientific voluntarily recalled certain lots of its Lotus Valve System, which is used in transcatheter aortic valve replacements. The system is not yet FDA-approved.

“Ian is one of the world’s leading cardiac device clinical investigators and he has been an advisor to Boston Scientific for many years,” Boston Scientific CEO and chairman Mike Mahoney said in a news release. “His strong relationships within the global research and clinical community and his track record applying novel technologies to advance science and care for patients make him ideally suited to drive innovation and succeed Keith in this role. We are delighted that he will be joining our team.”

Tim Casey,

Executive Editor

Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.

Related Content

Concomitant ablation surgery during heart operations boosts long-term survival
Cardiologist explores why colchicine failed to help heart attack patients
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Most heart failure patients miss out on guideline-recommended palliative care
Cardiologist behind EARLY TAVR explains how proactive treatment improves patient outcomes
FDA approves Medtronic’s new all-in-one mapping and ablation system for AFib

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."